Aligos Therapeutics, Inc. (ALGS)

NASDAQ: ALGS · Real-Time Price · USD

7.03

-0.47 (-6.27%)

At close: Feb 27, 2026, 4:00 PM EST

6.86

-0.17 (-2.38%)

After-hours: Feb 27, 2026, 7:11 PM EST

Aligos Therapeutics Market Cap

Aligos Therapeutics has a market cap or net worth of $43.26 million as of February 27, 2026. Its market cap has decreased by -44.52% in one year.

Market Cap

43.26M

Enterprise Value

-49.77M

1-Year Change

-44.52%

Ranking

#4644

Market Cap Chart

Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $43.26M, a decrease of -92.18%. That is a compound annual growth rate of -37.79%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	43.26M	-24.57%
Dec 31, 2025	57.35M	-61.21%
Dec 31, 2024	147.87M	197.20%
Dec 29, 2023	49.75M	21.95%
Dec 30, 2022	40.80M	-91.93%
Dec 31, 2021	505.85M	-52.00%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MiNK Therapeutics	51.78M
Estrella Immunopharma	51.07M
OS Therapies	50.36M
Kezar Life Sciences	49.14M
Impact BioMedical	45.51M
NextCure	45.50M
Telomir Pharmaceuticals	45.04M
Apollomics	43.75M

Market Cap Rankings